Nerandomilast is an oral antifibrotic medicine used in adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis. These conditions cause gradual scarring of lung tissue and increasingly difficult breathing. Nerandomilast inhibits the PDE4B enzyme, which is involved in inflammatory and fibrotic processes. It may slow the decline in lung function, but it does not cure existing lung scarring.
It is taken as tablets twice a day, as prescribed by a specialist in lung disease. Do not change the dose or stop treatment without medical advice. The doctor will assess lung function, tolerability, weight and general health. Tell the doctor about all medicines and supplements you use, because some may change the amount of nerandomilast in the body.
Side effects may include diarrhoea, nausea, reduced appetite and weight loss. These effects can affect nutrition and hydration, particularly in frail patients. Other digestive symptoms may also occur. If side effects are persistent or troublesome, the doctor may recommend supportive measures or adjust the dose depending on the situation.
Contact the doctor if diarrhoea is severe, you cannot maintain hydration, you lose weight rapidly or your breathing worsens. Seek urgent help for sudden severe breathlessness, chest pain or bluish lips. Tell the doctor if you are pregnant, breastfeeding or planning a pregnancy; information about use in these situations is limited. Attend regular follow-up appointments.